Questions discussed in this category
For medical oncologists, would you offer a PD-1/L1 inhibitor? For other subspecialties, how would you counsel the oncologist regarding the risk of usi...
1436811863
Papers discussed in this category
Journal of immunotherapy (Hagerstown, Md. : 1997), 2018-05
Neurology, 2019 Mar 08
Front Immunol, 2022 Aug 22